ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

A STUDY ON INSULIN GLARGINE IN THE TREATMENT OF ELDERLY PATIENTS WITH DIABETES

Dr Imran Khan, Dr M. Shujaat Karim, Dr Komal Shahid

Introduction: The prevalence of diabetes is increasing in Taiwan.1, 2 Diabetes is highly prevalent in elderly people. The rate of prevalence is ∼20% of the population aged ≥ 65 years in Taiwan, which presents a great burden to individuals, society, and health care services. Aims and objectives: The basic aim of the study is to analyse the role of insulin glargine in the treatment of elderly patients with diabetes. Material and methods: This cross sectional study was conducted in Saidu Medical College, Swat during January 2019 to July 2019. This study was conducted according to the ethical committee of hospital. The data was collected from 100 diabetic patients. We compare this data to the control patients. Both groups received conventional treatment. Results: The data was collected from 100 patients of both genders. We analyzed the factors between the patients with and without hypoglycemic control. It shows that the body mass index (BMI) at baseline was significantly lower in the patients with hypoglycemic episodes than in the patients without hypoglycemic episodes. In addition, the body weight gain after 24 weeks of insulin glargine in the patients with hypoglycemic episodes was significantly higher than that in the patients without hypoglycemic episodes. Conclusion: It is concluded that initiating basal insulin therapy with insulin glargine in elderly patients with OAD may provide effective glycemic control on HbA1c and FPG similar to those in younger patients.

FULL TEXT